wikioedia.org - Von http://web2.airmail.net/uthman/specimens/index.html, Gemeinfrei, https://commons.wikimedia.org/w/index.php?curid=841015FibrosisCough medicine reverses fibrosis in animal...Screening a library of 712 market-approved drugs, German researchers have found that a cough medicine most efficiently reduced incurable lung fibrosis in mice and in vitro. more ➔
Photys TherapeuticsPartnershipPhotys Therapeutics inks deal with Novo No...Novo Nordiks has licenced Photys Therapeutics PHICS platform to target a single cardiometabolic target. Photys got US$186m upfront. more ➔
DeepLife SASAI-guided screeningDeepLife raises US$10m in Series A financi...Generative AI specialist DeepLife SAS has raises US$10m in a Series A financing led by YZR Capital and Relyens Innovation Santé with participation from Beiersdorf Venture Capital, Prunay Group, and … more ➔
Wilfried Le Goff (INSERM, Sorbonne Université)ObesityMembrane target triggers inflammationResearchers at Sorbonne Paris have discovered that a membrane protein in adipocytes of obese mice and humans changes the lipid composition of adipose tissue macrophages rendering them more inflammatory … more ➔
Synaffix/LanzaADCsElevation Oncology Inc licences Synaffix B...Elevation Oncology Inc has inked a US$368m license agreement with Lonza subsidiary Synaffix BV under which Synaffix will link Elevation’s HER3 antibody seribantumab to a monomethyl auristatin E (MMAE) … more ➔
RSRTRNA editingRNA specialist ProQR Therapeutics NV bags...RNA editing specialist ProQR Therapeutics NV has deepened its collaboration with the Rett Syndrome Research Trust, which extented its funding of the preclinical MECP2 inhibitor AX-2402 to US$9.1m to … more ➔
Nobel Prize Outreach / Nanaka AdachiNobel PrizesBreakthroughs honoured: 2024 Nobel PrizesAs part of the 2024 Nobel Prize Week, the prestigious awards have been presented. These include the Nobel Prize in Medicine or Physiology for the discoverers of microRNAs as a new class of regulatory … more ➔
Pixabay- DeltaworksFinancingNoema Pharma AG extends Series B financingSwiss Noema Pharma AG has cashed in a CHF27m extention to its Series B financing that is used to advance four Phase II programmes in neurology. more ➔
Volker Brinkmann / Max Planck Institute for Infection BiologyFinancingCitryll BV raises €85m in Series B finan...Dutch inflammation specialist Citryll BV has raised €85m to push clininal testing of its lead candidate, CIT-013, a bifunctional antibody that prevents the release of neutrophil extracellular traps … more ➔
Dewpoint Therapeutics IncPartnershipsDewpoint Therapeutics and Mitsubishi Tanab...Dewpoint Therapeutics Inc and Mitsubishi Tanabe Pharma Corporation have formed a collaboration, valued at up to $480m, to develop a novel small molecule condensate modulator for ALS, leveraging groundbreaking … more ➔
wikioedia.org - Von http://web2.airmail.net/uthman/specimens/index.html, Gemeinfrei, https://commons.wikimedia.org/w/index.php?curid=841015
Photys Therapeutics
DeepLife SAS
Wilfried Le Goff (INSERM, Sorbonne Université)
Synaffix/Lanza
RSRT
Nobel Prize Outreach / Nanaka Adachi
Pixabay- Deltaworks
Volker Brinkmann / Max Planck Institute for Infection Biology
Dewpoint Therapeutics Inc